CNS antitumor activity of amivantamab added to osimertinib in EGFR-mutant non–small cell lung cancer with MET amplification as acquired resistance to osimertinib: a case report
{"title":"CNS antitumor activity of amivantamab added to osimertinib in EGFR-mutant non–small cell lung cancer with MET amplification as acquired resistance to osimertinib: a case report","authors":"Ebaa Al-obeidi, Jonathan Riess, David Gandara","doi":"10.53876/001c.90815","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":237891,"journal":{"name":"International Journal of Cancer Care and Delivery","volume":"41 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer Care and Delivery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53876/001c.90815","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}